An investigational drug is being tried on healthy volunteers for its safety and pharmacokinetic properties. Which of the following stages in the drug development process does this scenario most closely describe?
Select Your Answer:
Phase I trials aim to understand the safety and pharmacokinetic properties of an investigational drug.
Phase II trials aim to evaluate the efficacy of the a drug on small number of patients.
Phase III trials are done on a large number of patients to compare the efficacy of the new drug to that of a standard therapy or placebo.
*eMedicine, Google Scholar, UpToDate, WheelessOnline, and DermNet are not affiliated with StatPearls. We do not control their content or advertising.
Adult Lab Normals
Pediatric Lab Normals
Hypnotic agents for induction of general anesthesia in cesarean section patients: A systematic review and meta-analysis of randomized controlled trials., Houthoff Khemlani K,Weibel S,Kranke P,Schreiber JU,, Journal of clinical anesthesia, 2018 May 17 [PubMed]
Perspectives on the past, present, and future of cancer nanomedicine., Youn YS,Bae YH,, Advanced drug delivery reviews, 2018 May 17 [PubMed]
Concluding commentary on current trends to enhance the clinical safety of pediatric transfusion, focusing on prevention of untoward complications of HSC transplantation & newer strategies for improving the standards of safety/quality of stem cells expansion for cellur therapy., Sniecinski I,Seghatchian J,, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2018 May 16 [PubMed]
Novel Peptide Nanoparticle Biased Antagonist of CCR3 Blocks Eosinophil Recruitment and Airway Hyperresponsiveness., Grozdanovic M,Laffey KG,Abdelkarim H,Hitchinson B,Harijith A,Moon HG,Park GY,Rousslang LK,Masterson JC,Furuta GT,Tarasova NI,Gaponenko V,Ackerman SJ,, The Journal of allergy and clinical immunology, 2018 May 17 [PubMed]
Towards personalized medicine in the EU: what is needed to facilitate the complex international clinical research?, Lejeune S,Lacombe D,, Personalized medicine, 2013 Nov [PubMed]